New French regulations, mirroring similar rules in the United States, place health care and cosmetics companies operating in France with heavy disclosure requirement if they have any pecuniary relationship with researchers, universities, or any other third parties in connection with the marketing of their products. For a full bulletin on this development, please visit our sister blog, the Global Regulatory Enforcement Law Blog.